Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092

Yi Yu(Arqule (United States)), Brian Schwartz(Arqule (United States))
PLoS ONE
October 15, 2015
Cited by 121


Related Papers